Key facts
- This page summarizes ARCH Venture Partners IX, LLC's Form 4 filing for Beam Therapeutics Inc. (BEAM).
- 5 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 02 Jul 2021, 17:19.
ARCH Venture Partners IX, LLC - 30 Jun 2021 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- BEAM
- Reported as of
- 30 Jun 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Jul 2021, 17:19:09 UTC
- Prior SEC filing
- 29 Jun 2021
- Next SEC filing
- 06 Jul 2021
- Source filing
- View source filing
- Reporting owner signature
- By: ARCH Venture Partners IX, LLC, By: /s/ Mark McDonnell, as Attorney-in-Fact for Robert Nelsen, Managing Director
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
ARCH Venture Partners IX, LLC filed Form 4 for Beam Therapeutics Inc. (BEAM) on 02 Jul 2021.
Change
- Previous filing in this sequence was filed on 29 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BEAM
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -200,000
- Change %
- -6.4%
- Price
- $0.000000
- Shares after
- 2,921,520
- Date
- 30 Jun 2021
- Ownership
- See footnote
- Footnotes
- F1, F2
BEAM
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -200,000
- Change %
- -6.4%
- Price
- $0.000000
- Shares after
- 2,921,519
- Date
- 30 Jun 2021
- Ownership
- See footnote
- Footnotes
- F1, F3
BEAM
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +2,555
- Change %
- +20%
- Price
- $0.000000
- Shares after
- 15,328
- Date
- 30 Jun 2021
- Ownership
- Direct
- Footnotes
- F1, F4, F5
BEAM
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +811
- Change %
- +20%
- Price
- $0.000000
- Shares after
- 4,867
- Date
- 30 Jun 2021
- Ownership
- Direct
- Footnotes
- F1, F4, F6
BEAM
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +4,686
- Change %
- +20%
- Price
- $0.000000
- Shares after
- 28,111
- Date
- 30 Jun 2021
- Ownership
- Direct
- Footnotes
- F1, F4, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
ARCH Venture Partners IX, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 7 footnotes
Footnote F1
Distribution of Common Stock held by a limited partnership to its partners for no consideration.
Footnote F2
These shares are directly held by ARCH Venture Fund IX, L.P. ("ARCH IX"). ARCH Venture Partners IX, L.P. ("GPLP"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell, Robert Nelsen and Clinton Bybee (the "ARCH Managing Directors"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.
Footnote F3
These shares are directly held by ARCH Venture Fund IX Overage, L.P. ("ARCH Overage"). ARCH Venture Partners IX Overage, L.P. ("Overage GPLP"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.
Footnote F4
Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person.
Footnote F5
Shares held directly by Crandell.
Footnote F6
Shares held directly by Bybee.
Footnote F7
Shares held directly by Nelsen.